Affordable Access

Publisher Website

Quantitative effect of glycaemic improvement on the components of diabetic dyslipidaemia: a longitudinal study

Elsevier Ireland Ltd
Publication Date
DOI: 10.1016/j.diabres.2004.07.018
  • Type 2 Diabetes
  • Glycaemic Control
  • Diabetic Dyslipidaemia.
  • Biology
  • Medicine


Abstract In order to assess the effect of glycaemic improvement on lipoprotein concentrations, we studied 73 type 2 diabetic subjects before (HbA1c 10.1 (6.2–16)%) and after (HbA1c 6.6 (3.8–8.0)%) glycaemic improvement. Total triglyceride and cholesterol (c), LDLc, HDLc, non-HDLc and apolipoproteins AI (apoAI) and B (apoB) were measured. Bivariate correlations and step-wise, multivariate analysis were performed to find predictors of change in the different components of diabetic dyslipidaemia. Changes in HDLc ( r = −0.358, P = 0.001), apoAI ( r = −0.355, P = 0.003), apoAI/apoB ratio ( r = −0.333, P = 0.005), weight ( r = −0.245, P = 0.046) and BMI ( r = −0.253, P = 0.039) correlated with that of HbA1c, but, in multivariate analysis, only changes in HDLc, apoAI and apoAI/apoB ratio were predicted by the decrease in HbA1c. For the median observed change in HbA1c (−3.3 percentage-points), the estimated changes were +0.14 mmol/l, +0.12 g/l and +0.20 for HDLc, apoAI and apoAI/apoB ratio, respectively, accounting for 81, 92 and 80% of the observed changes. In conclusion, for the component of diabetic dyslipidaemia for which less therapeutic tools are available, glycaemic improvement is most effective.

There are no comments yet on this publication. Be the first to share your thoughts.